LC-UV and LC-MS evaluation of stress degradation behaviour of avizafone

Journal of Pharmaceutical and Biomedical Analysis

Volumn 41, Issue 4, 2006, Pages 1274-1279

  Breton, D ^a   Buret, D ^a   Mendes Oustric, A C ^a   Chaimbault, P ^b   Lafosse, M ^b   Clair, P ^a  

^a Pharmacie Centrale des Armées   (France)

^b UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Avizafone; Degradation; Liquid chromatography; Stress studies

Indexed keywords

AVIZAFONE; DIAZEPAM; UNCLASSIFIED DRUG;

ARTICLE; DEGRADATION; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG SCREENING; DRUG STRUCTURE; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; OXIDATIVE STRESS; PHOTOLYSIS; PRIORITY JOURNAL; SEIZURE; THERMAL ANALYSIS; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; DIPEPTIDES; DRUG STABILITY; REPRODUCIBILITY OF RESULTS;

EID: 33646846092     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.03.025     Document Type: Article

References (19)

1. Bajgar J. Adv. Clin. Chem. 38 (2004) 151-216
2. McDoough J., McMonagle J., Copeland T., Zoeffel D., and Shih T.M. Arch. Toxicol. 73 (1999) 473-478
3. Woreck F., Widmann R., Knopff O., and Szincz L. Arch. Toxicol. 72 (1998) 237-243
4. Capacio B.R., and Shih T.M. Epilepsia 32 (1991) 604-615
5. Maidment M., and Upshall D. J. Biopharm. Sci. 1 (1990) 19-32
6. Lallement G., Renault F., Baubichon D., Peoc'h M., Urckhart M.F., Galonnier M., Clarençon D., and Jourdil N. Arch. Toxicol. 74 (2000) 480-486
7. ICH Topic Q1A (R2): stability testing of new drug substances and products, in: Proceedings of the International Conference on Harmonisation, EMEA, London, 2003.
8. Carstensen J.T., Su K.S., Maddrel P., Johnson J.B., and Newmark H.N. Bull. Parenteral Drug Ass. 25 (1971) 193-202
9. Han W., Yakatan G., and Maness D. J. Pharm. Sci. 66 (1977) 573-577
10. Nudelman N.S., and Waibaum R.G. J. Pharm. Sci. 84 (1995) 208-211
11. Emery M., and Kowto J. J. Pharm. Sci. 68 (1979) 1185-1187
12. Fyllingen G., Kristiansen F., and Roksvaag P.O. Pharm. Acta Helv. 66 (1991) 44-46
13. Manucci C., Bertini J., Cocchini A., Perico A., Salvagani F., and Triolo A. J. Pharm. Sci. 82 (1993) 367-370
14. McClean S., O'Kane E., Hillis J., and Smyth W.F. J. Chromatogr. A 838 (1999) 273-291
15. Wang J., Shen X., Fenyk-Melody J., Pivnichny J.V., and Tong X. Rapid. Commun. Mass Spectrom. 17 (2003) 519-525
16. Walles M., Mullet W.M., and Pawliszin J. J. Chromatogr. A. 1025 (2004) 85-92
17. Mocak J., Bond A.M., Mitchell S., and Scollary G. Pure Appl. Chem. 69 (1997) 297-328
18. ICH Topic Q1B: photostability testing of new drug substances and products, in: Proceedings of the International Conference on Harmonisation, EMEA, London, 1996.
19. Clair P., Wiberg K., Granelli I., Carlsson Bratt I., and Blanchet G. Eur. J. Pharm. Sci. 9 (2000) 259-263